Cite
HARVARD Citation
Zhao, Y. et al. (n.d.). Early sorafenib‐related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients. International journal of cancer. 139 (4), pp. 928-937. [Online].